Clinical Trial Phases Explained: Phase 1 to Phase 4
Published March 28, 2026 · ClinicalTrials.gov data
Every new medical treatment must pass through a rigorous multi-phase testing process before reaching patients. Each phase answers different questions, from "Is this safe?" to "Does this work better than existing treatments?" Here is what happens in each phase, with real trial counts from our database.
Important: This is educational information, not medical advice. Talk to your doctor about whether a clinical trial is right for you.
The Four Phases
| Phase | Purpose | Size | Duration | Recruiting Now |
|---|---|---|---|---|
| Phase 1 | Safety, dosing | 20-80 | 6-12 months | ~1,500 |
| Phase 2 | Efficacy, side effects | 100-300 | 1-2 years | ~2,800 |
| Phase 3 | Definitive efficacy | 1,000-3,000 | 2-4 years | ~2,200 |
| Phase 4 | Post-approval monitoring | Varies | Ongoing | ~800 |
Phase 1: Is It Safe?
Phase 1 is the first time a treatment is tested in humans. The primary goal is to determine safe dosage levels and identify side effects. Participants are usually healthy volunteers (for non-cancer drugs) or patients who have exhausted standard treatments (for cancer drugs). These trials are small, typically 20-80 participants.
Phase 2: Does It Work?
Phase 2 trials test whether the treatment actually works for the target condition. They also continue monitoring safety with a larger group (100-300 participants). This is where many drugs fail, roughly 50-60% of drugs that pass Phase 1 do not demonstrate sufficient efficacy to advance.
Phase 3: The Definitive Test
Phase 3 trials are the gold standard. They compare the new treatment against the current best treatment (or placebo, if no standard treatment exists) in large groups of 1,000-3,000+ patients. These are typically randomized, double-blind trials, neither the patient nor the doctor knows who receives the experimental treatment. FDA approval decisions are primarily based on Phase 3 results.
Phase 4: Real-World Monitoring
Phase 4 trials study FDA-approved treatments in broader real-world populations. They monitor long-term safety, identify rare side effects, and explore new uses. From a patient perspective, Phase 4 trials carry the least uncertainty because the treatment has already been approved.
For guidance on finding trials, see how to find a clinical trial. For cancer-specific trials, see cancer trials recruiting now.
Frequently Asked Questions
What is the difference between Phase 1, 2, 3, and 4 trials?
Phase 1 tests safety and dosing in a small group (20-80). Phase 2 tests effectiveness in a larger group (100-300). Phase 3 is the definitive test comparing the new treatment to existing treatments in a large group (1,000-3,000). Phase 4 monitors already-approved treatments in real-world use.
Which phase of clinical trial is most risky?
Phase 1 trials carry the most uncertainty because the treatment has never been tested in humans before. However, serious adverse events in Phase 1 are still relatively rare, extensive preclinical testing (lab and animal studies) is required before human trials begin.
How long does each clinical trial phase take?
Phase 1: typically 6-12 months. Phase 2: 1-2 years. Phase 3: 2-4 years. Phase 4: ongoing (years). The entire drug development process from discovery to approval averages 10-15 years.
What percentage of drugs make it through all phases?
Approximately 10-15% of drugs that enter Phase 1 ultimately receive FDA approval. The biggest drop-off occurs between Phase 2 and Phase 3, where roughly 50-60% of drugs fail due to insufficient efficacy.
About This Data
Trial counts from ClinicalTrials.gov API v2. This is educational information, talk to your doctor about clinical trials. See our methodology.